Crossmark

Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation

Crossref DOI link: https://doi.org/10.1038/s41379-020-0496-1

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Williams, David S.

Mouradov, Dmitri

Newman, Marsali R.

Amini, Elham

Nickless, David K.

Fang, Catherine G.

Palmieri, Michelle

Sakthianandeswaren, Anuratha

Li, Shan

Ward, Robyn L.

Hawkins, Nicholas J.

Skinner, Iain

Jones, Ian

Gibbs, Peter

Sieber, Oliver M. https://orcid.org/0000-0001-9480-0786
Funding

Funding for this research was provided by:

Austin Medical Research Foundation (Project Grant)

State Government of Victoria (Operational Infrastructure Support Program, Operational Infrastructure Support Program)

Cancer Australia (APP1120882)

Cancer Council Victoria (1060964)

Department of Health | National Health and Medical Research Council (APP1136119)
License Information

Text and Data Mining valid from 2020-07-01

Version of Record valid from 2023-01-11
More Information

This article is maintained by: Elsevier

Article Title: Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-020-0496-1

Content Type: article

Copyright: © 2020 United States & Canadian Academy of Pathology.

Document is current

Any future updates will be listed below